BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹303 Cr | ₹339 Cr | ₹304 Cr | ₹281 Cr | ₹251 Cr |
What is the latest Revenue of BAL PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹303 Cr |
| Mar2024 | ₹339 Cr |
| Mar2023 | ₹304 Cr |
| Mar2022 | ₹281 Cr |
| Mar2021 | ₹251 Cr |
How is Revenue of BAL PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹303 Cr | -10.65 | |
| Mar2024 | ₹339 Cr | 11.51 | |
| Mar2023 | ₹304 Cr | 8.18 | |
| Mar2022 | ₹281 Cr | 12.25 | |
| Mar2021 | ₹251 Cr | - | |
Compare Revenue of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹135.5 Cr | -3.5% | 9.2% | -11.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,145.0 Cr | -0.1% | -2.5% | 6.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,989.0 Cr | -0.2% | -2.8% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,322.0 Cr | 2.3% | 1.2% | 41.1% | Stock Analytics | |
| CIPLA | ₹112,149.0 Cr | 0.7% | 1.9% | -4.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,483.0 Cr | 0.1% | -2.4% | 2.3% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -3.5% |
9.2% |
-11.9% |
| SENSEX | -1% |
-5.7% |
-9.7% |
You may also like the below Video Courses